ClassID:

21437

A61K49/0058 - CPC Classification

Classification description:

Preparations for testing; Preparation for luminescence or biological staining; Luminescence; Fluorescence characterised by the carrier molecule carrying the fluorescent agent Antibodies

Recent Application in this class:
#1
20260139066
2026-05-21

ANTI-UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS

#2
20260131036
2026-05-14

CD138/SYNDECAN1 ANTIBODIES AND METHODS OF USE THEREOF

#3
20260108636
2026-04-23

MULTI-MODAL MOLECULAR IMAGING NANOPROBE FOR EARLY WARNING AND DYNAMIC MONITORING OF ATHEROSCLEROTIC PLAQUES AND USE THEREOF

#4
20260053938
2026-02-26

DIELS-ALDER CONJUGATION METHODS

#5
20260028406
2026-01-29

NANOBODY BASED IMAGING AND TARGETING OF ECM IN DISEASE AND DEVELOPMENT

#6
20260001943
2026-01-01

ANTI-ELASTIN ANTIBODIES AND METHODS OF USE

#7
20250339564
2025-11-06

EPITHELIAL CELL ADHESION MOLECULE (EPCAM)-FLUORESCENCE IMAGING MOLECULE FOR THE DETECTION OF GASTROINTESTINAL TUMORS AND CANCER POSITIVE LYMPH NODES

#8
20250332291
2025-10-30

MONOCLONAL ANTIBODIES FOR TARGETING THE CARDIAC CONDUCTION SYSTEM

#9
20250320289
2025-10-16

Identification of B-Cell and T-Cell Receptor Chains for Diagnosis and Treatment of Inflammatory Diseases

#10
20250281633
2025-09-11

HER2 TARGETING FC ANTIGEN BINDING FRAGMENT-DRUG CONJUGATES

#11
20250263475
2025-08-21

Anti-P53 Antibodies

#12
20250262332
2025-08-21

FLUOROCHEMICAL TARGETED THERAPIES

#13
20250249125
2025-08-07

ANTI-CD90 ANTIBODIES, BINDING FRAGMENTS, AND USES THEREOF

#14
20250236680
2025-07-24

ANTI-PSMA ANTIBODIES, VARIANTS, AND USES THEREOF

#15
20250215073
2025-07-03

ANTIBODY FRAGMENT SPECIFIC TO C-KIT POSITIVE TUMORS

#16
20250176833
2025-06-05

FC DOMAIN IMAGING PROBES AND METHODS OF USE THEREOF

#17
20250171523
2025-05-29

CAMELID ANTI-SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS ANTIBODIES

#18
20250127934
2025-04-24

HIGH-BRIGHTNESS FLUOROPHORES

#19
20250082204
2025-03-13

IMAGING SYSTEMS AND METHODS FOR TISSUE DIFFERENTIATION, E.G., FOR INTRAOPERATIVE VISUALIZATION

#20
20250041459
2025-02-06

Polyethylene Glycol Modified Zwitterionic Fluorescent Probe and Application Thereof, and Preparation

#21
20250027944
2025-01-23

FLOW CYTOMETRY-BASED PLATFORM FOR THE DETECTION, ENUMERATION, AND ISOLATION OF DISSEMINATED TUMOR CELLS IN BONE MARROW ASPIRATES

#22
20250025569
2025-01-23

TISSUE-SPECIFIC IMAGING AND THERAPEUTIC AGENTS TARGETING PROTEINS EXPRESSED ON MUSCLE CELL SURFACE

#23
20250009908
2025-01-09

Fluorescently Labeled Immunoglobulin Single Variable Domains

#24
20250000364
2025-01-02

GASTROINTESTINAL TRACT DETECTION METHODS, DEVICES AND SYSTEMS

#25
20240422409
2024-12-19

Endoscopic System to Capture Images of a Medical Site in White Light and Fluorescent Light

#26
20240417452
2024-12-19

ANTI-MESOTHELIN NANOBODIES AND USE THEREOF

#27
20240409637
2024-12-12

ANTI-CD8 ANTIBODIES AND USES THEREOF

#28
20240409630
2024-12-12

ANTI-FOLATE RECEPTOR ANTIBODIES, COMPOSITIONS COMPRISING ANTI-FOLATE RECEPTOR ANTIBODIES AND METHODS OF MAKING AND USING ANTI-FOLATE RECEPTOR ANTIBODIES

#29
20240398998
2024-12-05

ACTIVATABLE ANTIBODIES THAT BIND EPIDERMAL GROWTH FACTOR RECEPTOR AND METHODS OF USE THEREOF

#30
20240366799
2024-11-07

CAGING-GROUP-FREE PHOTOACTIVATABLE FLUORESCENT DYES AND THEIR USE

#31
20240360228
2024-10-31

ANTI-CCR8 ANTIBODIES, ANTIGEN-BINDING FRAGMENTS THEREOF, AND AGENTS AND COMPOSITIONS AND METHODS FOR MAKING AND USING THE SAME

#32
20240352118
2024-10-24

ANTI-TIGIT ANTIBODY AND USE THEREOF

#33
20240343820
2024-10-17

ANTIGEN BINDING MOLECULES AND METHODS OF USE

#34
20240337658
2024-10-10

COMPOSITIONS AND METHODS FOR DETECTING PROTEASE ACTIVITY IN BIOLOGICAL SYSTEMS

#35
20240309113
2024-09-19

NOVEL ANTI-MASP-2 ANTIBODIES

#36
20240277672
2024-08-22

SITE-SPECIFIC ANTIBODY-DRUG GLYCONJUGATES AND METHODS

#37
20240260909
2024-08-08

Method and apparatus for medical imaging using differencing of multiple fluorophores

#38
20240252537
2024-08-01

PRECISION MOLECULAR ADAPTOR SYSTEM FOR CAR-T IMMUNOTHERAPY

#39
20240247068
2024-07-25

NOVEL PROTEIN SPECIFICALLY BINDING TO CALRETICULIN AND HAVING HUMAN FIBRONECTIN DOMAIN III SCAFFOLD AND USE THEREOF

#40
20240239874
2024-07-18

Fully Human Monoclonal Antibodies that Broadly Neutralize SARS-COV-2

#41
20240238451
2024-07-18

SINGLE-DOMAIN ANTIGEN-DEPENDENT ANTIBODY-LIKE FUSION PROTEINS

#42
20240228648
2024-07-11

ANTI-CD38 ANTIBODY AND USE THEREOF

#43
20240228639
2024-07-11

CD70 ANTI-IDIOTYPE ANTIBODIES

#44
20240226311
2024-07-11

Improved immunoglobulin II

#45
20240216556
2024-07-04

PEPTIDE-FC FUSIONS FOR TREATING AMYLOID DISORDERS

#46
20240216548
2024-07-04

METHOD FOR PREPARING THERAGNOSTIC CARBON QUANTUM-DOT NANOMEDICINES FOR TARGETED DRUG DELIVERY TO ACUTE-MYELOID LEUKEMIA

#47
20240216524
2024-07-04

Chemoselective Rapid Azo-Coupling Reaction for Bioconjugation

#48
20240209099
2024-06-27

NOVEL ANTI-HVEGFR2 ANTIBODIES

#49
20240209088
2024-06-27

NOVEL SINGLE DOMAIN ANTIGEN BINDING MOLECULES AND THEIR USES

#50
20240207412
2024-06-27

DIELS-ALDER CONJUGATION METHODS

#51
20240190947
2024-06-13

CAMELID ANTI-SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS ANTIBODIES

#52
20240181095
2024-06-06

A DELTA-OPIOID RECEPTOR TARGETED AGENT FOR MOLECULAR IMAGING AND IMMUNOTHERAPY OF CANCER

#53
20240174645
2024-05-30

COMPOUND, PRODUCTION METHOD THEREFOR, COMPLEX, AND SHORT WAVELENGTH INFRARED FLUORESCENT AGENT

#54
20240141043
2024-05-02

BISPECIFIC ANTIBODY THAT BINDS TO CD3 AND A FLUOROPHORE

#55
20240141038
2024-05-02

ANTIBODY AGAINST NKP46 AND APPLICATION THEREOF

#56
20240140909
2024-05-02

HEPTAMETHINE CYANINES FOR USE AS FLUORESCENT MARKERS OF THE BILIARY AND RENAL SYSTEMS

#57
20240132481
2024-04-25

COMPOUND AND LABELED BIOLOGICAL SUBSTANCE USING THE SAME

#58
20240131200
2024-04-25

REPORTER PROTEIN FUSED ANTIBODIES

#59
20240124558
2024-04-18

ANTIBODIES BINDING TO SARS-COV-2 VIRUS AND USES THEREOF

#60
20240108745
2024-04-04

BIOACTIVE SUBSTANCE CONJUGATE, PREPARATION METHOD THEREFOR AND USE THEREOF

#61
20240101710
2024-03-28

B-CELL MATURATION ANTIGEN (BCMA) ANTI-IDIOTYPIC ANTIBODIES

#62
20240101706
2024-03-28

DEVELOPMENT OF NEW MONOCLONAL ANTIBODIES RECOGNIZING HUMAN PROSTATE-SPECIFIC MEMBRANE ANTIGEN (PSMA)

#63
20240067746
2024-02-29

THERAPEUTIC ANTIBODIES

#64
20240058455
2024-02-22

BIOORTHOGONAL LINKERS AND REACTIONS

#65
20240042062
2024-02-08

COMPOSITIONS AND METHODS FOR ENHANCED FLUORESCENCE

#66
20240018263
2024-01-18

ANTIBODIES TARGETING GLIOBLASTOMA STEM-LIKE CELLS AND METHODS OF USE THEREOF

#67
20240018217
2024-01-18

Fully Human Monoclonal Antibodies that Broadly Neutralize SARS-COV-2

#68
20240000977
2024-01-04

METHODS AND KITS FOR DIAGNOSING AND TREATING CANCERS

#69
20230414529
2023-12-28

PROTEINOID COMPOUNDS, PROCESS OF PREPARING SAME AND USES THEREOF

#70
20230404908
2023-12-21

Compositions And Methods For Treating With A Combination Of Alternating Electric Fields And Trastuzumab

#71
20230382857
2023-11-30

HEPTAMETHINE CYANINES FOR USE AS FLUORESCENT MARKERS OF THE BILIARY AND RENAL SYSTEMS

#72
20230372525
2023-11-23

TRANSGLUTAMINASE CONJUGATION METHOD WITH AMINO ACID-BASED LINKERS

#73
20230364270
2023-11-16

LIPOSOME-ASSISTED IMAGING OF VASCULAR INFLAMMATION

#74
20230348605
2023-11-02

NANOBODY BASED IMAGING AND TARGETING OF ECM IN DISEASE AND DEVELOPMENT

#75
20230265189
2023-08-24

Anti-PD-1 Antibodies

#76
20230257457
2023-08-17

Anti-p53 antibodies

#77
20230241253
2023-08-03

NIR-conjugated tumor-specific antibodies and uses thereof

#78
20230235034
2023-07-27

MONOCLONAL ANTIBODIES AGAINST PATHOLOGICAL TAU, AND METHODS USING SAME

#79
20230233157
2023-07-27

Method and apparatus for medical imaging using differencing of multiple fluorophores

#80
20230212283
2023-07-06

MATRIX METALLOPROTEASE-CLEAVABLE AND SERINE PROTEASE-CLEAVABLE SUBSTRATES AND METHODS OF USE THEREOF

#81
20230211000
2023-07-06

Tissue-homing peptide conjugates and methods of use thereof

#82
20230159762
2023-05-25

NIR TO SWIR FLUORESCENT COMPOUNDS FOR IMAGING AND DETECTION

#83
20230159639
2023-05-25

Anti-CD8 antibodies and uses thereof

#84
20230144004
2023-05-11

Delta-opioid receptor targeted agent for molecular imaging and immunotherapy of cancer

#85
20230121556
2023-04-20

COMPOUNDS FOR FAST AND EFFICIENT CLICK RELEASE

#86
20230115540
2023-04-13

TUMOR TARGETED FLUORESCENCE GUIDANCE FOR INTRAOPERATIVE MARGIN ASSESSMENT

#87
20230068124
2023-03-02

Hydrazinyl-Indole Compounds and Methods for Producing a Conjugate

#88
20230066723
2023-03-02

MICROPARTICLE COMPOSITIONS

#89
20230050584
2023-02-16

PHOTOSENSITIZING ANTIBODY-FLUOROPHORE CONJUGATES

#90
20230049618
2023-02-16

TUMOR SPECIFIC ANTIBODY CONJUGATES AND USES THEREFOR

#91
20230037294
2023-02-09

NANOPARTICLE IMMUNOCONJUGATES

#92
20230021301
2023-01-19

Matrix metalloprotease-cleavable and serine protease-cleavable substrates and methods of use thereof

#93
20220411506
2022-12-29

CTLA4 ANTIBODY, PHARMACEUTICAL COMPOSITION AND USE THEREOF

#94
20220403042
2022-12-22

Therapeutic antibodies

#95
20220380453
2022-12-01

Matrix metalloprotease-cleavable and serine protease-cleavable substrates and methods of use thereof

#96
20220378951
2022-12-01

Specific conjugation linkers, specific immunoconjugates thereof, methods of making and uses such conjugates thereof

#97
20220378949
2022-12-01

NEUROTROPHIN RECEPTOR BINDING CONJUGATE COMPOSITIONS, METHODS OF USE AND METHODS OF MAKING THEREOF

#98
20220378918
2022-12-01

Diels-alder conjugation methods

#99
20220323616
2022-10-13

NOVEL MOLECULAR TOOLS TO VISUALIZE AND TARGET THE CARDIAC CONDUCTION SYSTEM (CCS)

#100
20220323345
2022-10-13

HUMANIZED ANTIBODY FOR SARS-CoV-2 SPIKE PROTEIN INFUSION

#101
20220306759
2022-09-29

ANTI-CD71 ANTIBODIES, ACTIVATABLE ANTI-CD71 ANTIBODIES, AND METHODS OF USE THEREOF

#102
20220305139
2022-09-29

IMMUNE MICROBUBBLE COMPLEX, AND USE THEREOF

#103
20220298245
2022-09-22

ANTI-PDL1 ANTIBODIES, ACTIVATABLE ANTI-PDL1 ANTIBODIES, AND METHODS OF USE THEREOF

#104
20220288210
2022-09-15

Photosensitizing antibody-fluorophore conjugates

#105
20220280659
2022-09-08

Targeted Nanoparticles of Well-Defined and Reproducible Sizes

#106
20220273823
2022-09-01

THERANOSTIC CONJUGATES

#107
20220265866
2022-08-25

METHODS FOR ANALYZING TUMOR INNATE IMMUNE INTERACTIONS USING THE ZEBRAFISH XENOGRAFT MODEL AS A LIVING BIOMARKER

#108
20220227886
2022-07-21

ANTIBODY-BASED METHOD TO IDENTIFY, PURIFY, AND MANIPULATE CELL TYPES AND PROCESSES

#109
20220226509
2022-07-21

HIGH-BRIGHTNESS NANODOT FLUOROPHORES BY COVALENT FUNCTIONALIZATION

#110
20220191439
2022-06-16

Apparatus, system and method to capture images of a medical site in white light and fluorescent light

#111
20220175977
2022-06-09

COMPOUNDS AND METHODS FOR THE DETECTION OF TRPV-6 CANCERS AND DRUG DELIVERY

#112
20220175972
2022-06-09

Fluorochemical targeted therapies

#113
20220168433
2022-06-02

PROGRAMMABLE POLYMERIC DRUGS

#114
20220160887
2022-05-26

PROGRAMMABLE POLYMERIC DRUGS

#115
20220133913
2022-05-05

SINGLE DOMAIN ANTIBODY TARGETING aVB3 INTEGRIN

#116
20220133904
2022-05-05

TRANSGLUTAMINASE CONJUGATION METHOD WITH A GLYCINE BASED LINKER

#117
20220111063
2022-04-14

ANTIBODY-DRUG CONJUGATES AND USE OF ANTIBODIES FOR DRUG DELIVERY

#118
20220089706
2022-03-24

ANTI-ELASTIN ANTIBODIES AND METHODS OF USE

#119
20220088212
2022-03-24

C-terminal lysine conjugated immunoglobulins

#120
20220031867
2022-02-03

Glymphatic delivery by manipulating plasma osmolarity

#121
20220024904
2022-01-27

REAGENT FOR BIOCONJUGATION VIA IRREVERSIBLE REBRIDGING OF DISULFIDE LINKAGES

#122
20220001042
2022-01-06

CEACAM1 MEDIATED PROTECTIVE IMMUNITY

#123
20220001041
2022-01-06

CEACAM1 BASED CANCER THERAPY AND DIAGNOSIS

#124
20210382053
2021-12-09

Compositions and methods for detecting protease activity in biological systems

#125
20210364507
2021-11-25

SWCNT-DNA-ANTIBODY CONJUGATES, RELATED COMPOSITIONS, AND SYSTEMS, METHODS AND DEVICES FOR THEIR USE

#126
20210355208
2021-11-18

MATRIX METALLOPROTEASE-CLEAVABLE AND SERINE PROTEASE-CLEAVABLE SUBSTRATES AND METHODS OF USE THEREOF

#127
20210353777
2021-11-18

SPECIFIC CONJUGATION LINKERS, SPECIFIC IMMUNOCONJUGATES THEREOF, METHODS OF MAKING AND USES SUCH CONJUGATES THEREOF

#128
20210347886
2021-11-11

MATRIX METALLOPROTEASE-CLEAVABLE AND SERINE PROTEASE-CLEAVABLE SUBSTRATES AND METHODS OF USE THEREOF

#129
20210346523
2021-11-11

Specific conjugation linkers, specific immunoconjugates thereof, methods of making and uses such conjugates thereof

#130
20210333209
2021-10-28

Highly specific tissue imaging

#131
20210277141
2021-09-09

Anti-PSMA antibodies and use thereof

#132
20210277122
2021-09-09

Anti-PD-1 antibodies

#133
20210277107
2021-09-09

Epitope specific antibodies that bind cell surface GRP78 and their use for cancer detection

#134
20210260205
2021-08-26

CARTILAGE-HOMING PEPTIDE CONJUGATES AND METHODS OF USE THEREOF

#135
20210238270
2021-08-05

COMPOSITION AND METHOD FOR THE DIAGNOSIS AND TREATMENT OF DISEASES ASSOCIATED WITH NEURITE DEGENERATION

#136
20210198196
2021-07-01

Non-aggregating heptamethine cyanine fluorophores for in vivo imaging

#137
20210196127
2021-07-01

Methods for collecting and testing bacteria containing samples from within the gastrointestinal tract

#138
20210162054
2021-06-03

Hydrazinyl-indole compounds and methods for producing a conjugate

#139
20210147542
2021-05-20

Anti-CD8 antibodies and uses thereof

#140
20210137894
2021-05-13

Site-specific antibody-drug glyconjugates and methods

#141
20210113711
2021-04-22

Conjugated biological molecules, pharmaceutical compositions and methods

#142
20210100919
2021-04-08

Heptamethine cyanines for use as fluorescent markers of the biliary and renal systems

#143
20210095014
2021-04-01

Methods of lowering triglyceride levels with an ANGPTL8-binding antibody or antigen-binding fragment thereof

#144
20210055309
2021-02-25

Tau imaging ligands and their uses in the diagnosis and treatment of tauopathy

#145
20210052747
2021-02-25

Specific conjugation linkers, specific immunoconjugates thereof, methods of making and uses such conjugates thereof

#146
20210023243
2021-01-28

Activatable antibodies that bind epidermal growth factor receptor and methods thereof

#147
20210017288
2021-01-21

Periostin antibodies and methods of using the same

#148
20210017132
2021-01-21

Non-aggregating heptamethine cyanine fluorophores for in vivo imaging

#149
20200383576
2020-12-10

Apparatus, systems and methods for intraoperative imaging

#150
20200368372
2020-11-26

NIR-CONJUGATED TUMOR-SPECIFIC ANTIBODIES AND USES THEREOF

#151
20200354472
2020-11-12

Antibodies targeting glioblastoma stem-like cells and methods of use thereof

#152
20200353096
2020-11-12

NANOPARTICLE IMMUNOCONJUGATES

#153
20200338128
2020-10-29

PRECISION MOLECULAR ADAPTOR SYSTEM FOR CAR-T IMMUNOTHERAPY

#154
20200330616
2020-10-22

BIOMIMETIC NON-IMMUNOGENIC NANOASSEMBLY FOR THE ANTITUMOR THERAPY

#155
20200330610
2020-10-22

Compositions and methods for enhanced fluorescence

#156
20200308295
2020-10-01

Anti-C3d antibody conjugates and methods of detecting complement activation

#157
20200282075
2020-09-10

ALBUMIN-MODIFIED NANOPARTICLES CARRYING A TARGETING LIGAND

#158
20200277362
2020-09-03

Humanized antibodies that recognize alpha-synuclein

#159
20200261603
2020-08-20

Anti-human MUC1 antibody Fab fragment

#160
20200261602
2020-08-20

Compositions and methods for enhanced fluorescence

#161
20200231677
2020-07-23

Anti-PDL1 antibodies, activatable anti-PDL1 antibodies, and methods of use thereof

#162
20200221954
2020-07-16

Gastrointestinal tract detection methods, devices and systems

#163
20200215206
2020-07-09

Specific conjugation linkers, specific immunoconjugates thereof, methods of making and uses such conjugates thereof

#164
20200209263
2020-07-02

INCOMPATIBLE BLOOD GROUP ANTIGEN FOR CANCER DETECTION AND TREATMENT

#165
20200207868
2020-07-02

HER3 binding agents and uses thereof

#166
20200197530
2020-06-25

DELTA-OPIOID RECEPTOR TARGETED AGENT FOR MOLECULAR IMAGING AND IMMUNOTHERAPY OF CANCER

#167
20200190187
2020-06-18

Anti-PD-1 antibodies

#168
20200188535
2020-06-18

Bioorthogonal Turn-on Probes

#169
20200171174
2020-06-04

NOVEL ANTI-HUMAN MUC1 ANTIBODY FAB FRAGMENT

#170
20200166510
2020-05-28

Flow cytometry-based platform for the detection, enumeration, and isolation of disseminated tumor cells in bone marrow aspirates

#171
20200165329
2020-05-28

Camelid single-domain antibody directed against phosphorylated tau proteins and methods for producing conjugates thereof

#172
20200155707
2020-05-21

Conjugate and block copolymer containing fluorescent chromophore and preparation method therefor and use thereof

#173
20200148783
2020-05-14

METHODS AND COMPOSITION FOR SECRETION OF HETEROLOGOUS POLYPEPTIDES

#174
20200140541
2020-05-07

Antibodies that bind cell surface GRP78

#175
20200138980
2020-05-07

METHODS AND COMPOSITIONS FOR THE DETECTION OF CANCER

#176
20200121790
2020-04-23

Near-IR light-cleavable conjugates and conjugate precursors

#177
20200108154
2020-04-09

ANTI-TPBG ANTIBODIES AND METHODS OF USE

#178
20200108140
2020-04-09

ANTIBODIES TO IL-6 AND USE THEREOF

#179
20200102376
2020-04-02

Modified variable domain molecules and methods for producing them

#180
20200095331
2020-03-26

Photosensitizing antibody-fluorophore conjugates

#181
20200093921
2020-03-26

ANTAGONISTS OF IL-6 TO RAISE ALBUMIN AND/OR LOWER CRP

#182
20200087405
2020-03-19

EGFR-binding agents and uses thereof

#183
20200085963
2020-03-19

CELL PENETRATING PROTEIN ADAPTOR MOLECULES AND THEIR APPLICATION IN RESEARCH AND MEDICINE

#184
20200085950
2020-03-19

Photosensitizing antibody-fluorophore conjugates

#185
20200069812
2020-03-05

Cartilage-homing peptide conjugates and methods of use thereof

#186
20200061216
2020-02-27

Tumor specific antibody conjugates and uses therefor

#187
20200046857
2020-02-13

Reporter protein fused antibodies

#188
20200029887
2020-01-30

METHOD OF ASSESSING WOUND CONTAMINATION AND INFECTION

#189
20200025761
2020-01-23

Compositions and methods for detecting protease activity in biological systems

#190
20200017558
2020-01-16

Modified biotin, streptavidin mutant, and usage of them

#191
20200016276
2020-01-16

Antibody-drug conjugates based on gold compounds

#192
20200009263
2020-01-09

C-terminal lysine conjugated immunoglobulins

#193
20190382493
2019-12-19

Anti-PDL1 antibodies, activatable anti-PDL1 antibodies, and methods of use thereof

#194
20190375819
2019-12-12

GLYCOSYLATED TRANSFERRIN RECEPTOR 1 TUMOR ANTIGEN

#195
20190374662
2019-12-12

Modulation of immunity and CEACAM1 activity

#196
20190367632
2019-12-05

Therapeutic antibodies

#197
20190367615
2019-12-05

Antibody specifically binding to PD-1 and functional fragment thereof

#198
20190367589
2019-12-05

ANTI-JAGGED 1/JAGGED 2 CROSS-REACTIVE ANTIBODIES, ACTIVATABLE ANTI-JAGGED ANTIBODIES AND METHODS OF USE THEREOF

#199
20190330367
2019-10-31

Development of new monoclonal antibodies recognizing human prostate-specific membrane antigen (PSMA)

#200
20190322723
2019-10-24

Peptide-Mediated Non-Covalent Delivery of Active Agents Across the Blood-Brain Barrier

#201
20190314509
2019-10-17

Hydrazinyl-indole compounds and methods for producing a conjugate

#202
20190307906
2019-10-10

Anti-human MUC1 antibody Fab fragment

#203
20190298861
2019-10-03

IN VIVO SELECTION OF THERAPEUTICALLY ACTIVE ANTIBODIES

#204
20190276526
2019-09-12

COMPOSITION AND METHOD FOR THE DIAGNOSIS AND TREATMENT OF DISEASES ASSOCIATED WITH NEURITE DEGENERATION

#205
20190269804
2019-09-05

Anti-human MUC1 antibody fab fragment

#206
20190256588
2019-08-22

Antibody specifically binding to IL-17A, encoding nucleic acid, and method of using the antibody

#207
20190248879
2019-08-15

Anti-p53 antibodies

#208
20190247318
2019-08-15

PROTEINOID COMPOUNDS, PROCESS OF PREPARING SAME AND USES THEREOF

#209
20190241652
2019-08-08

MATRIX METALLOPROTEASE-CLEAVABLE AND SERINE PROTEASE-CLEAVABLE SUBSTRATES AND METHODS OF USE THEREOF

#210
20190240355
2019-08-08

Light-Emitting Versions of the Monoclonal Antibody to C3D (MAB 3D29) for Imaging

#211
20190233512
2019-08-01

ANTI-FOLATE RECEPTOR ANTIBODIES, COMPOSITIONS COMPRISING ANTI-FOLATE RECEPTOR ANTIBODIES AND METHODS OF MAKING AND USING ANTI-FOLATE RECEPTOR ANTIBODIES

#212
20190225693
2019-07-25

Nanobody based imaging and targeting of ECM in disease and development

#213
20190218295
2019-07-18

Anti-PD-1 antibodies

#214
20190218290
2019-07-18

CAMEL DERIVED POLYPEPTIDES BINDING HUMAN CD3, IDENTIFIED USING A NOVEL ONE-STEP METHOD

#215
20190212335
2019-07-11

AIE Nanoparticle Conjugates And Methods Therefor

#216
20190209717
2019-07-11

Compounds and methods for the detection of TRPV-6 cancers and drug delivery

#217
20190202927
2019-07-04

Anti-CD71 antibodies, activatable anti-CD71 antibodies, and methods of use thereof

#218
20190194319
2019-06-27

ANTI-ASCL1 ANTIBODIES AND METHODS OF USE

#219
20190169281
2019-06-06

ANGPTL8-binding agents and methods of use thereof

#220
20190167793
2019-06-06

Near-IR light-cleavable conjugates and conjugate precursors

#221
20190153080
2019-05-23

Humanized antibodies that recognize alpha-synuclein

#222
20190106507
2019-04-11

Antibody-drug conjugates containing anti-Globo H antibodies and uses thereof

#223
20190100654
2019-04-04

NIR to SWIR fluorescent compounds for imaging and detection

#224
20190091349
2019-03-28

Antigen responsive antibody-fluorescent dye conjugate and method for fluorescence detection and imaging of target cell using the same

#225
20190084964
2019-03-21

Benzocyanine compounds

#226
20190077853
2019-03-14

Camelid single-domain antibody directed against phosphorylated tau proteins and methods for producing conjugates thereof

#227
20190071517
2019-03-07

Antibody binding to HEG1 and use of the antibody for detection and treatment of mesothelioma

#228
20190070318
2019-03-07

Reporter platform for real time monitoring of drug efficacy

#229
20190070317
2019-03-07

In-vivo reactive species imaging

#230
20190025331
2019-01-24

Tau imaging ligands and their uses in the diagnosis and treatment of tauopathy

#231
20190024152
2019-01-24

Identification of selected spectrum antibiotics

#232
20190023790
2019-01-24

Anti-CD8 antibodies and uses thereof

#233
20190002544
2019-01-03

Blood-brain barrier permeable peptide compositions comprising a VAB domain of an anti-amyloid-beta camelid single-domain heavy-chain only antibody

#234
20190000969
2019-01-03

NOVEL ANTI-UPK1B ANTIBODIES AND METHODS OF USE

#235
20190000320
2019-01-03

Apparatus, systems and methods for intraoperative imaging

#236
20180372735
2018-12-27

Use of fluorescence for the quick and easy determination of S-adenosylmethionine, S-adenosylhomocysteine and homocysteine

#237
20180360984
2018-12-20

Chemoselective rapid azo-coupling reaction for bioconjugation

#238
20180333507
2018-11-22

Activatable antibodies that bind epidermal growth factor receptor and methods of use thereof

#239
20180326102
2018-11-15

SYSTEMS, METHODS, AND COMPOSITIONS FOR IMAGING ANDROGEN RECEPTOR AXIS ACTIVITY IN CARCINOMA, AND RELATED THERAPEUTIC COMPOSITIONS AND METHODS

#240
20180312608
2018-11-01

Antibody-based molecules selective for the Ser404 epitope of Tau and their uses in the diagnosis and treatment of tauopathy

#241
20180311371
2018-11-01

Anti-TPBG antibodies and methods of use

#242
20180296705
2018-10-18

HIGH-BRIGHTNESS FLUOROPHORES

#243
20180265577
2018-09-20

DNA molecules encoding antibodies to tau and methods of making thereof

#244
20180251544
2018-09-06

ANTI-HUMAN FOLATE RECEPTOR BETA ANTIBODIES AND METHODS OF USE

#245
20180221512
2018-08-09

NIR-conjugated tumor-specific antibodies and uses thereof

#246
20180209986
2018-07-26

Compositions and methods for detecting cancer cells in a tissue sample

#247
20180206769
2018-07-26

Gastrointestinal tract detection methods, devices and systems

#248
20180206726
2018-07-26

GASTROINTESTINAL TRACT DETECTION METHODS, DEVICES AND SYSTEMS

#249
20180193485
2018-07-12

Nanoparticle composition for use in targeting cancer stem cells and method for treatment of cancer

#250
20180193481
2018-07-12

Conjugated biological molecules, pharmaceutical compositions and methods

#251
20180185525
2018-07-05

CEACAM1 BASED CANCER THERAPY AND DIAGNOSIS

#252
20180184950
2018-07-05

IMAGING DEVICE AND METHOD FOR DETECTION OF DISEASE

#253
20180177902
2018-06-28

CEACAM1 MEDIATED PROTECTIVE IMMUNITY

#254
20180177897
2018-06-28

Rhodol fluorophores for near-infrared imaging

#255
20180153407
2018-06-07

Methods, Systems, and Devices for Imaging Microscopic Tumors

#256
20180134689
2018-05-17

Benzocyanine compounds

#257
20180133345
2018-05-17

Nano-Devices for Detection and Treatment of Cancer

#258
20180133342
2018-05-17

Nanoparticle immunoconjugates

#259
20180126009
2018-05-10

Fluorescent conjugates

#260
20180117184
2018-05-03

Quantum Dots for Diagnostic Imaging

#261
20180104354
2018-04-19

CHIMERIC ANTIGEN RECEPTOR T CELL SWITCHES AND USES THEREOF

#262
20180104351
2018-04-19

Hydrazinyl-indole compounds and methods for producing a conjugate

#263
20180094054
2018-04-05

ANTIBODIES THAT BIND CELL SURFACE GRP78 AND THEIR USE FOR DETECTION OF CANCER

#264
20180092999
2018-04-05

Method of treating allergic asthma with antibodies to IL-6

#265
20180092993
2018-04-05

COMPOSITIONS AND METHODS FOR ENHANCED FLUORESCENCE

#266
20180079906
2018-03-22

AZACYANINE DYES AND USE THEREOF

#267
20180078641
2018-03-22

Method for treating infectious diseases using emissive energy

#268
20180043038
2018-02-15

TUMOR SPECIFIC ANTIBODY CONJUGATES AND USES THEREFOR

#269
20180043010
2018-02-15

Antagonists of IL-6 to raise albumin and/or lower CRP

#270
20180017561
2018-01-18

TH17-PRONE CD146+CCR5+ T-CELL POPULATION AS AN EARLY MARKER OF INTESTINAL GRAFT-VERSUS-HOST DISEASE

#271
20180016352
2018-01-18

TARGETING CONSTRUCTS FOR DELIVERY OF PAYLOADS

#272
20180016329
2018-01-18

Humanized antibodies that recognize alpha-synuclein

#273
20180002340
2018-01-04

Benzopyrylium compounds

#274
20170348438
2017-12-07

MRP-14 targeting peptides and uses thereof

#275
20170335012
2017-11-23

Antibodies specific for urokinase-type plasminogen activator and methods of use thereof for treating cancer

#276
20170298142
2017-10-19

Antibodies to GRP78

#277
20170298125
2017-10-19

Anti-jagged 1/jagged 2 cross-reactive antibodies, activatable anti-jagged antibodies and methods of use thereof

#278
20170290930
2017-10-12

Light-emitting versions of the monoclonal antibody to C3D (MAB 3D29) for imaging

#279
20170252466
2017-09-07

Early disease detection and therapy

#280
20170240619
2017-08-24

MODIFIED VARIABLE DOMAIN MOLECULES AND METHODS FOR PRODUCING THEM

#281
20170212131
2017-07-27

Tau imaging ligands and their uses in the diagnosis and treatment of tauopathy

#282
20170198007
2017-07-13

METHODS FOR IDENTIFICATION OF SITES FOR IGG CONJUGATION

#283
20170196996
2017-07-13

Activatable antibodies that bind epidermal growth factor receptor and methods of use thereof

#284
20170173175
2017-06-22

Site-specific antibody-drug glycoconjugates and methods

#285
20170145076
2017-05-25

Peptide-mediated non-covalent delivery of active agents across the blood-brain barrier

#286
20170145063
2017-05-25

Modified biotin, streptavidin mutant, and usage of them

#287
20170143233
2017-05-25

Magnetic probes for in vivo capture and detection of extracellular vesicles

#288
20170115307
2017-04-27

Methods of aiding in the diagnosis of diseases using anti-IL-6 antibodies

#289
20170107292
2017-04-20

Antagonists for abdominal vasopressin V2 receptor and uses thereof

#290
20170089922
2017-03-30

Methods and compositions for wound treatment

#291
20170080110
2017-03-23

Method of binding a CSE1L tumor marker in a tumor of an animal

#292
20170058022
2017-03-02

Camelid single-domain antibody directed against phosphorylated tau proteins and methods for producing conjugates thereof

#293
20170042827
2017-02-16

Proteinoid compounds, process of preparing same and uses thereof

#294
20170035915
2017-02-09

Fluorescent conjugates

#295
20170035908
2017-02-09

Detection of Early-Stage Pancreatic Adenocarcinoma

#296
20170022277
2017-01-26

Insulin-like growth factor 1 receptor-specific antibodies and uses thereof

#297
20170008970
2017-01-12

Antibodies comprising C-terminal light chain polypeptide extensions and conjugates and methods of use thereof

#298
20160374559
2016-12-29

Methods, systems, and devices for imaging microscopic tumors

#299
20160355599
2016-12-08

Anti-CD71 antibodies, activatable anti-CD71 antibodies, and methods of use thereof

#300
20160355575
2016-12-08

Oligopeptide and methods for producing conjugates thereof